Short answer There’s no one “best” BHRT delivery form for everyone. Choice depends on which hormone(s) you need, your health risks, how quickly you want dose changes, and how you tolerate routes of administration. Patches and FDA‑approved transdermal gels/creams give predictable, adjustable systemic dosing and have better safety data than many compounded products. Pellets give very steady long‑term release and convenience but are less adjustable and are usually compounded (limited high‑quality outcome data). Quick comparison (pros/cons) Pellets (subcutaneous implants) Pros: long‑acting (3–6 months), steady hormone levels, good for people who don’t want daily dosing. Cons: office procedure to insert/remove, dose isn’t easily changed once placed, variable dosing between compounding pharmacies, limited long‑term randomized data, potential for site infection or extrusion. Typical use: people wanting low‑maintenance, continuous delivery. Creams/gels (topical/transdermal) Pros: noninvasive, easy to stop or change dose, can be compounded to combine hormones, lower first‑pass liver effects than oral estrogens. Cons: variable absorption between people, risk of transfer to partners/children if not covered/wash hands, many compounded creams lack consistent potency. Typical use: dose flexibility, topical testosterone for women, or localized vaginal estrogen (for vaginal symptoms). Patches (transdermal) Pros: steady, predictable systemic delivery, well‑studied FDA‑approved options available, easy to start/stop, generally lower clot risk than oral estrogens. Cons: skin irritation, need regular changes (often 1–2× weekly), patches usually deliver estrogen only (you may still need progesterone if you have a uterus). Typical use: reliable systemic estrogen replacement with good monitoring options. Safety and evidence points “Bioidentical” simply means chemically identical to human hormones; it doesn’t guarantee safety or quality. Some bioidentical hormones are available as FDA‑approved products (e.g., estradiol patch, FDA‑approved micronized progesterone), while many compounded BHRT products (especially pellets and custom creams) are not FDA‑tested for consistency or clinical outcomes. Transdermal routes (patch/gel) are generally associated with lower hepatic first‑pass effects and have been linked to lower venous thromboembolism risk than oral estrogen in several studies. Pellets are less well studied in randomized trials; risk profiles may differ. If you have a uterus, you still need adequate progestogen to prevent endometrial hyperplasia when taking systemic estrogen. Always monitor symptoms and labs with a clinician experienced in hormone therapy. Who offers them (brands / services) Pellets (most are compounded; clinics/brands that provide them) BioTE Medical — well‑known pellet program and a national network of trained providers; marketed as an easy, long‑acting option. SottoPelle — international pellet therapy system/clinics focused on pellet insertion and follow‑up. Local anti‑aging/integrative clinics and compounding pharmacies — many physicians insert customized compounded pellets made by compounding pharmacies. (Because pellets are usually compounded, results and quality depend on the clinic/pharmacy.) Transdermal patches (FDA‑approved brands for estradiol) Climara, Vivelle‑Dot, Alora, Minivelle, Menostar — established estradiol patch products that deliver predictable systemic estrogen and are prescribed by primary care, gynecology, or endocrinology. Topical/gels and creams Estrace (prescription estradiol cream) — FDA‑approved for local vaginal symptoms. Evamist (estradiol transdermal spray) — prescription product for systemic estrogen delivery. Compounded topical creams and gels — available from compounding pharmacies such as Wedgewood Pharmacy, Empower Pharmacy, Fagron, etc., when individualized combinations or doses are requested. (Quality and consistency vary; ask the pharmacy about USP‑quality practices.) OTC topical progesterone creams (e.g., Emerita Pro‑Gest) exist but are not FDA‑regulated for systemic hormonal replacement; potency and bioavailability are inconsistent. How to choose a provider/product If you want standardized, well‑studied dosing and easier reversibility: consider FDA‑approved patches or transdermal gels prescribed by a board‑certified OB‑GYN, internist or endocrinologist experienced in menopause/hormone therapy. If adherence is a problem and you prefer few clinic visits: pellets (BioTE, SottoPelle or a compounding‑pellet clinic) may be attractive — but weigh the downsides (irreversible until metabolized, less evidence). If you want customized hormone mixes/doses (e.g., low‑dose testosterone for women), compounding pharmacies and practitioners who work with them can make tailored creams or pellets — but confirm quality controls and monitoring plans. Ask any prospective provider: Are the hormones FDA‑approved or compounded? What experience/credentials do you have? How will you monitor symptoms and labs? How do you manage side effects or overdosing? Next steps Talk with a clinician (OB‑GYN, endocrinologist or family physician with menopause/BHRT experience). Bring your medical history (clotting history, breast cancer risk, liver disease, current meds). If you want names locally, tell me your city/zip and whether you prefer in‑person clinics or telemedicine and I can suggest nearby practices/networks (e.g., BioTE or SottoPelle trained providers, BodyLogicMD clinics, specialized menopause clinics). If you’d like, tell me which hormones you’re considering (estrogen alone, estrogen+progesterone, testosterone) and any important health history and I’ll give a more personalized pros/cons and provider recommendations.
Mentioned in position 13 of 14
Read full answer with sources →